Press-release for stocks related to drug

Prices are updated after-hours

tags : Drug

save search

Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1
Published: 2023-12-07 (Crawled : 17:00) - biospace.com/
DARE | News | $0.319 -8.15% -8.87% 6.8M

Health Technology

| -0.74% | O: -7.52% H: 0.0% C: 0.0%
fda drug bioscience clearance application

Lexaria's Investigational New Drug Application Filing Update
Published: 2023-12-07 (Crawled : 15:30) - biospace.com/
LEXX | News | $1.475 -2.32% -2.37% 42K

Health Technology

| 0.0% | O: -8.44% H: 0.0% C: 0.0%
drug update application

Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business
Published: 2023-12-07 (Crawled : 14:30) - globenewswire.com
MLCT | News | $0.1415 -1.06% 7.2K

Manufacturing

| Email alert Add to watchlist
VBIO | News | $ 0%

Manufacturing

| Email alert Add to watchlist
drug business

Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1, a Novel Intravaginal Formulation of Tamoxifen for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy Associated with Menopause
Published: 2023-12-07 (Crawled : 13:00) - globenewswire.com
DARE | News | $0.319 -8.15% -8.87% 6.8M

Health Technology

| -0.74% | O: -7.52% H: 0.0% C: 0.0%
fda drug bioscience clearance application

Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
Published: 2023-12-07 (Crawled : 06:00) - globenewswire.com
GNFT | News | $3.14 -1.88% -1.91% 48K

Health Technology

| Email alert Add to watchlist
fda rare drug liver review treatment application grants

Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State
Published: 2023-12-06 (Crawled : 14:30) - globenewswire.com
SCLX | $1.08 -5.26% -5.56% 830K

| 0.0% | O: 0.0% H: 0.0% C: 0.0%
ztlido drug company state one

Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
PHAT | $8.26 -2.48% -2.54% 950K

Health Technology

| 6.07% | O: 6.07% H: 0.0% C: 0.0%
voquezna fda drug treatment pharmaceuticals application

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea
Published: 2023-12-06 (Crawled : 12:30) - globenewswire.com
IXHL | $5.88 -13.15% -15.14% 100K

Manufacturing

| 24.89% | O: 24.89% H: 0.0% C: 0.0%
ihl-42 drug candidate update ihl-42x trial

Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
Published: 2023-12-06 (Crawled : 12:00) - globenewswire.com
OPTN | $1.25 1.63% 1.6% 490K

Health Services

| -14.89% | O: -14.89% H: 0.0% C: 0.0%
fda xhance drug review extension application

Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NBIX M | $119.97 0.42% 0.42% 880K

Health Technology

| 3.02% | O: 3.02% H: 0.0% C: 0.0%
drug food designation therapy

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab)
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M

Health Technology

| Email alert Add to watchlist
drug opdivo review food application

Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
INBS | $0.313 -5.15% -5.43% 910K

Manufacturing

| 1.35% | O: 10.27% H: 10.92% C: -8.09%
drug solution

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
Published: 2023-12-05 (Crawled : 12:30) - globenewswire.com
ADPT | $4.67 1.08% 1.07% 970K

Commercial Services

| -5.76% | O: 1.07% H: 0.95% C: -6.75%
clonoseq drug biotechnologies cancer blood care meeting

BridgeBio Pharma Announces Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Published: 2023-12-05 (Crawled : 12:30) - bridgebio.com
BBIO | $33.61 3.7% 3.57% 1.4M

Health Technology

| 1.96% | O: 1.96% H: 0.0% C: 0.0%
pharma drug food treatment application submission

Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
Published: 2023-12-05 (Crawled : 07:00) - prnewswire.com
CLVT | $8.04 1.39% -1.62% 3.6M

Information

| -2.11% | O: -1.87% H: 1.27% C: -0.25%
partnership drug life research

Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 1.08% | O: 0.08% H: 0.0% C: 0.0%
VNDA | News | $3.96 -1.98% -2.02% 1.5M

Health Technology

| 0.89% | O: 0.13% H: 1.53% C: 0.76%
drug food treatment pharmaceuticals application

Scilex Holding Company announces the addition of ZTlido® (lidocaine topical system) as a preferred agent to the Medicaid Preferred Drug List (PDL) of the State of Tennessee
Published: 2023-12-04 (Crawled : 14:00) - globenewswire.com
SCLX | $1.08 -5.26% -5.56% 830K

| -7.09% | O: 10.63% H: 0.0% C: 0.0%
ztlido drug company state

J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery
Published: 2023-12-04 (Crawled : 13:30) - biospace.com/
JNJ | News | $155.4 -0.78% -0.02% 6.4M

Health Technology

| 1.3% | O: 0.98% H: 0.0% C: 0.0%
drug